By Katherine Dillinger, CNN (CNN) — The US Food and Drug Administration is evaluating reports of side effects such as hair loss and suicidal thoughts in people taking medications like Ozempic, Mounjaro and Wegovy. These drugs, known as GLP-1 receptor agonists, are approved to treat diabetes or weight loss. They include semaglutide, branded as Ozempic, Rybelsus and Wegovy; liragutide, branded as Saxenda and Victoza; and tirzepatide, branded as Mounjaro and Zepbound. They mimic GLP-1, a hormone made naturally in the body whose roles include slowing the passage of food through the stomach. The FDA is “evaluating the need for regulatory action” after its FDA Adverse Event Reporting System
Hence then, the article about fda looking into reports of hair loss suicidal thoughts in people using popular drugs for diabetes and weight loss was published today ( ) and is available onNews channel ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details Finally We wish PressBee provided you with enough information of ( FDA looking into reports of hair loss, suicidal thoughts in people using popular drugs for diabetes and weight loss )